Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- PRCHN’s Darcy Freedman presents on developing, implementing healthy food incentive programs
- Art lecturer Christopher Pekoc’s work on display at Akron Art Museum
- Law’s Jonathan Adler publishes works, presents around the country
- Law Professor Cassandra Robertson publishes, presents on variety of legal issues
- Engineering’s Mehran Mehregany publishes wireless health textbook